Low risk prostate cancer according to d'Amico (T1-T2a and PSA \<10 ng/ml, and Gleason score 6) or intermediate risk prostate cancer according d'Amico but excluding tumor with Gleason score 7 (4 + 3),
Indication of a curative treatment by brachytherapy validated in multidisciplinary consultation meeting,
You may not be if
Androgen deprivation therapy,
Contraindication for prostate Iodine 125 brachytherapy (Prostate volume \> 50 cc, impossibility if general anesthesia).
Contraindication for Resonance Magnetic Imagery (RMI) (claustrophobia, pacemaker)
Participation to another research which could have an impact on the study treatment and the outcomes
Clareo Health | Erectile Dysfunction in Good Prognosis Prostate Cancer : Comparison Between Brachytherapy and Stereotactic Body Radiotherapy
